دورية أكاديمية
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia
| العنوان: | Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia |
|---|---|
| المؤلفون: | Rosario Di Maggio, Matthew M. Hsieh, Xiongce Zhao, Giuseppina Calvaruso, Paolo Rigano, Disma Renda, John F. Tisdale, Aurelio Maggio |
| المصدر: | International Journal of Molecular Sciences, Vol 19, Iss 3, p 681 (2018) |
| بيانات النشر: | MDPI AG, 2018. |
| سنة النشر: | 2018 |
| المجموعة: | LCC:Biology (General) LCC:Chemistry |
| مصطلحات موضوعية: | sickle cell disease, sickle beta thalassemia, hydroxyurea, fetal hemoglobin, Biology (General), QH301-705.5, Chemistry, QD1-999 |
| الوصف: | In sickle cell disease (SCD), hydroxyurea (HU) treatment decreases the number of vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) by increasing fetal hemoglobin (HbF). Data are lacking regarding the frequency of HU dose modification or whether sub-therapeutic doses ( |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1422-0067 19030681 |
| Relation: | http://www.mdpi.com/1422-0067/19/3/681; https://doaj.org/toc/1422-0067 |
| DOI: | 10.3390/ijms19030681 |
| URL الوصول: | https://doaj.org/article/5851d9f3693749c187a2e69c3e197b49 |
| رقم الأكسشن: | edsdoj.5851d9f3693749c187a2e69c3e197b49 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 14220067 19030681 |
|---|---|
| DOI: | 10.3390/ijms19030681 |